Eisai Co., Ltd. (TYO:4523)
Japan · Delayed Price · Currency is JPY 5,186.00
+16.00 (0.31%)
Nov 13, 2026, 3:30 PM JST
Eisai Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 895,326 | 825,378 | 789,400 | 741,751 | 744,402 | 756,226 |
Revenue Growth | 11.30% | 4.56% | 6.42% | -0.36% | -1.56% | 17.07% |
Gross Profit Gross Profit Growth | 687,665 | 634,155 | 620,593 | 586,418 | 566,565 | 581,395 |
Operating Income Operating Income Growth | 59,877 | 44,139 | 47,071 | 44,085 | 38,435 | 42,435 |
Net Income Net Income Growth | 43,859 | 38,558 | 46,432 | 42,406 | 55,432 | 47,954 |
Earnings Per Share EPS Growth | 155.59 | 136.78 | 163.76 | 147.86 | 193.31 | 167.25 |
EPS Growth | -11.12% | -16.47% | 10.76% | -23.51% | 15.58% | 13.85% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceutical Business - Japan (Including Pharmaceutical Business - OTC and Others) Pharmaceutical Business - Japan (Including Pharmaceutical Business - OTC and Others) Growth | 233,375 | 229,238 | 216,281 | 216,935 | - | - |
Pharmaceutical Business - Americas Pharmaceutical Business - Americas Growth | 338,003 | 300,440 | 278,259 | 232,381 | 212,742 | 172,016 |
Pharmaceutical Business - China Pharmaceutical Business - China Growth | 147,135 | 130,745 | 115,539 | 111,928 | 110,768 | 106,420 |
Pharmaceutical Business - EMEA Pharmaceutical Business - EMEA Growth | 86,426 | 81,532 | 79,397 | 75,989 | 72,159 | 59,339 |
Pharmaceutical Business - East Asia Global South Pharmaceutical Business - East Asia Global South Growth | 74,626 | 68,823 | 59,555 | 54,226 | 49,839 | 50,632 |
Other Business Other Business Growth | 15,761 | 14,599 | 40,369 | 50,293 | 59,969 | 129,945 |
Total Total Growth | 895,326 | 825,377 | 789,400 | 741,752 | 744,404 | 756,227 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 317,466 | 245,423 | 265,561 | 304,678 | 267,350 | 309,633 |
Total Debt Total Debt Growth | 254,943 | 186,081 | 187,522 | 159,405 | 126,105 | 94,893 |
Net Cash (Debt) Net Cash Growth | 62,523 | 59,342 | 78,039 | 145,273 | 141,245 | 214,740 |
Net Cash Growth | -3.78% | -23.96% | -46.28% | 2.85% | -34.23% | 35.19% |
Net Cash Per Share Net Cash Per Share Growth | 221.80 | 210.51 | 275.24 | 506.53 | 492.55 | 748.93 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 68,798 | 61,323 | 30,117 | 55,993 | -1,772 | 117,590 |
Capital Expenditures CapEx Growth | -18,401 | -15,359 | -11,933 | -14,321 | -22,576 | -29,031 |
Free Cash Flow Free Cash Flow Growth | 50,397 | 45,964 | 18,184 | 41,672 | -24,348 | 88,559 |
Free Cash Flow Growth | 31.27% | 152.77% | -56.36% | - | - | 61.88% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 76.81% | 76.83% | 78.62% | 79.06% | 76.11% | 76.88% |
Operating Margin | 6.69% | 5.35% | 5.96% | 5.94% | 5.16% | 5.61% |
Pretax Margin | 6.22% | 6.18% | 7.74% | 8.33% | 6.05% | 7.20% |
Profit Margin | 4.90% | 4.67% | 5.88% | 5.72% | 7.45% | 6.34% |
FCF Margin | 5.63% | 5.57% | 2.30% | 5.62% | -3.27% | 11.71% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 160.000 | 160.000 | 160.000 | 160.000 | 160.000 | 160.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 3.08% | 3.28% | 3.86% | 2.58% | 2.13% | 2.82% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.33 | 35.61 | 25.16 | 42.04 | 38.82 | 33.90 |
Forward PE | 23.37 | 25.21 | 23.13 | 37.44 | 70.72 | 40.10 |
P/FCF Ratio | 29.07 | 29.87 | 64.26 | 42.78 | - | 18.36 |
PS Ratio | 1.64 | 1.66 | 1.48 | 2.40 | 2.89 | 2.15 |